Carnitine system in uremic patients: Molecular and clinical aspects

Seminars in Nephrology

Volumn 24, Issue 5, 2004, Pages 464-468

  Savica, Vincenzo ^a,d   Calvani, Menotti ^b   Benatti, Paola ^b   Santoro, Domencio ^b   Monardo, Paolo ^a   Peluso, Gianfranco ^c   Bellinghieri, Guido ^b  

^a Papardo Hospital   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c Italy   (United States)

^d NONE   (Italy)

Author keywords

c reactive protein; carnitine; carnitine molecular aspect; inflammation; insulin resistance

Indexed keywords

C REACTIVE PROTEIN; CARNITINE; CYTOKINE; ERYTHROPOIETIN; FATTY ACID; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOSE; INSULIN; MEPYRAMINE; PROTEIN; TETRYLAMMONIUM; VALPROIC ACID; VERAPAMIL; WATER;

ANTIINFLAMMATORY ACTIVITY; BODY MASS; CARNITINE DEFICIENCY; CHRONIC INFLAMMATION; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE COURSE; DRUG EFFECT; DYSLIPIDEMIA; ERYTHROPOIESIS; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; GLUCOSE METABOLISM; HEALTH STATUS; HEART ARRHYTHMIA; HEART DISEASE; HEMODIALYSIS; HUMAN; HYPOTENSION; IMMUNOMODULATION; INSULIN RESISTANCE; LETHARGY; MITOCHONDRION; MOLECULAR BIOLOGY; MUSCLE CRAMP; MUSCLE WEAKNESS; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN METABOLISM; RECEPTOR UPREGULATION; RECURRENT DISEASE; SOLUBILITY; SUPPLEMENTATION; SYMPTOM; TRANSCRIPTION REGULATION; TREATMENT OUTCOME; UREMIA;

CARNITINE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; RENAL DIALYSIS; UREMIA;

EID: 5444257488     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2004.06.023     Document Type: Conference Paper

References (53)

1. I.B. Fritz The effect of muscle extracts on the oxidation of palmitic acid by liver slices and homogenates Acta Physiol Scand 34 1995 367 385
2. C.J. Rebouche, H. Seim Carnitine metabolism and its regulation in microorganisms and mammals Annu Rev Nutr 18 1998 39 61
3. P.R. Borum Carnitine Ann Rev Nutr 3 1983 233 259
4. G. Peluso, R. Nicolai, E. Reda Cancer and anticancer therapy-induced modifications on metabolism mediated by carnitine system J Cell Physiol 182 2000 339 350
5. R.R. Ramsay, R.D. Gandour, F.R. van der Leij Molecular enzymology of carnitine transfer and transport Biochim Biophys Acta 1546 2001 21 43
6. I. Tamai, H. Yabuuchi, J. Nezu Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1 FEBS Lett 419 1997 107 111
7. X. Wu, W. Huang, P.D. Prasad Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter J Pharmacol Exp Ther 290 1999 1482 1492
8. J. Nezu, I. Tamai, A. Oku Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter Nat Genet 21 1999 91 94
9. M.S.R. Murthy, S.V. Pande Molecular biology of carnitine palmitoyltransferases and role of carnitine in gene transcription C. de Simone G. Famularo Carnitine Today 1997 Springer-Verlag Heidelberg 39 70
10. G. Peluso, A. Barbarisi, V. Savica Carnitine An osmolyte that plays a metabolic role J Cell Biochem 80 2001 1 10
11. G. Peluso, O. Petillo, A. Barbarisi Carnitine protects the molecular chaperone activity of lens alpha-crystallin and decreases the post-translation protein modifications induced by oxidative stress FASEB J 15 2001 1604 1606
12. J. Bremer Carnitine. Metabolism and functions Physiol Rev 64 1983 1420 1480
13. S.H. Chen, S.D. Lincoln Increased serum carnitine concentration in renal insufficiency Clin Chem 23 1977 278 280
14. T. Bohmer, A. Rydning, H.E. Solberg Carnitine levels in human serum in health and disease Clin Chim Acta 57 1974 55 61
15. T.A. Golper, M. Wolfson, S. Ahmad Multicenter trial of L-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects Kidney Int 38 1990 904 911
16. S. Rodriguez-Segade, C. del la Pena, M. Paz Carnitine concentrations in dialysed and undialysed patients with chronic renal insufficiency Ann Clin Biochem 23 1986 671 675
17. V. Savica, G. Bellinghieri, C. Di Stefano Plasma and muscle carnitine levels in hemodialysis patients with morphological-ultrastructural examination of muscle samples Nephron 35 1983 232 236
18. A.V. Moorthy, M. Rosenblum, R. Rajaram A comparison of plasma and muscle carnitine levels in patients on peritoneal or hemodialysis for chronic renal failure Am J Nephrol 3 1983 205 208
19. S. Goral Levocarnitine and muscle metabolism in patients with end-stage renal disease J Ren Nutr 8 1998 118 121
20. L.G. Spagnoli, G. Palmieri, A. Mauriello Morphometric evidence of the trophic effect of L-carnitine on human skeletal muscle Nephron 55 1990 16 23
21. G.A. Kaysen, F.T. Stevenson, T.A. Depner Determinants of albumin concentration in hemodialysis patients Am J Kidney Dis 29 1997 658 668
22. J. Bergström, O. Heimbürger, B. Lindholm Elevated serum C-reactive protein is a strong predictor of increased mortality and low serum albumin in hemodialysis (HD) patients J Am Soc Nephrol 6 1995 573
23. J. Zimmermann, S. Herrlinger, A. Pruy Inflammation enhances cardiovascular risk and mortality in hemodialysis patients Kidney Int 55 1999 648 658
24. P.L. Kimmel, T.M. Phillips, S.J. Simmens Immunologic function and survival in hemodialysis patients Kidney Int 54 1998 236 244
25. B.R. Bistrian, J. Schwartz, N.W. Istfan Cytokines, muscle proteolysis, and the catabolic response to infection and inflammation Proc Soc Exp Biol Med 200 1992 220 223
26. R.F. Grimble Inflammatory status and insulin resistance Curr Opin Clin Nutr Metab Care 5 2002 551 559
27. G. Delogu, C. De Simone, G. Famularo Anaesthetics modulate tumour necrosis factor alpha: Effects of L-carnitine supplementation in surgical patients. Preliminary results Mediators Inflamm 2 1993 S33 S36
28. A.T. Yilmaz, M. Arslan, U. Demirkilic Can preoperative administration of carnitine avoid the cytokine promoted by CBP? Isr J Med Sci 32 1996 938 (abstr)
29. C. De Simone, S. Tzantzoglou, G. Famularo High dose L-carnitine improves immunologic and metabolic parameters in AIDS patients Immunopharmacol Immunotoxicol 15 1993 1 12
30. N.M. Kouttab, C. De Simone Modulation of cytokine production by carnitine Mediators Inflamm 2 1993 S25 S28
31. Savica V, Santoro D, Ciolino F,, et al. L-carnitine infusions may suppress serum C-reactive protein and improve nutritional status in maintenance hemodialysis patients. J Renal Nutr (in press)
32. S. Alesci, M.U. De Martino, M. Mirani L-carnitine A nutritional modulator of glucocorticoid receptor functions FASEB J 17 2003 1553 1555
33. H.A. Feldman, I. Singer Endocrinology and metabolism in uremia and dialysis A clinical review Medicine 54 1974 345 376
34. A. Linder, B. Charra, D.J. Sherpard Accelerated atherosclerosis in prolonged maintenance hemodialysis N Engl J Med 290 1974 697 701
35. J.F. Moorhead, M.K. Chan, Z. Varghese The role of abnormalities of lipid metabolism in the progression of renal disease B.M. Brenner J.H. Stein The Progressive Nature of Renal Disease 1986 Churchill Livingstone New York 133 149
36. T. Ikeda, T. Gomi, N. Hirawa Improvement of insulin sensitivity contributes to blood pressure reduction after weight loss in hypertensive subjects with obesity Hypertension 27 1996 1180 1186
37. R.H.K. Mak, R.A. DeFronzo Glucose and insulin metabolism in uremia Nephron 61 1992 377 382
38. E. Neubaurer Über hyperglykaemia bei hochdrucknephritis und die beziehungen zwischen glykaemie und glycosurie beim diabetes mellitus Biochem Z 25 1910 285 298
39. R.H.K. Mak Renal disease, insulin resistance and glucose intolerance Diabetes 2 1994 19 28
40. R.A. DeFronzo, J.D. Tobin, J.W. Rowe Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin J Clin Invest 63 1978 425 435
41. B.B. Rasmussen, U.C. Holmback, E. Volpi Malonyl coenzyme A and the regulation of functional carnitine palmitoyltransferase-1 activity and fat oxidation in human skeletal muscle J Clin Invest 110 2002 1687 1693
42. A.I. Gunal, H. Celiker, E. Donder The effect of L-carnitine on insulin resistance in hemodialysed patients with chronic renal failure J Nephrol 12 1999 38 40
43. G. Panzetta, N. Tessitore, E. Valvo Improvement of post-dialysis glucose intolerance by dialysate carnitine supplementation Proc Eur Dial Transplant Assoc 22 1985 127 130
44. G. Peluso, P. Benatti, R. Nicola Carnitine system and insulin resistance G. Crepaldi A. Tiengo S. Del Prato International Congress Series, Insulin Resistance, Metabolic Diseases and Diabetic Complications 1177 1999 Elsevier Science Publishers 259 274
45. G. Mingrone, A.V. Greco, E. Capristo L-carnitine improves glucose disposal in type 2 diabetic patients J Am Coll Nutr 18 1999 77 82
46. A. De Gaetano, G. Mingrone, M. Castagneto Carnitine increases glucose disposal in humans J Am Coll Nutr 18 1999 289 295
47. G. Nanni, A. Chiodini, G. Rascente Activity of L-carnitine on hormono-metabolic variations during infusion of glucose solution Int J Tissue React 2 1980 181 193
48. E. Ferrannini, G. Buzzigoli, S. Bevilacqua Interaction of carnitine with insulin-stimulated glucose metabolism in humans Am J Physiol 255 1988 E946 E952
49. B. Capaldo, R. Napoli, P. Di Bonito Carnitine improves peripheral glucose disposal in non-insulin-dependent diabetic patients Diabetes Res Clin Pract 14 1991 191 195
50. G. Peluso, O. Petillo, S. Margarucci Decreased mitochondrial carnitine translocase in skeletal muscles impairs utilization of fatty acids in insulin-resistant patients Front Biosci 7 2002 A109 A116
51. A.M. Evans, R. Faull, G. Fornasini Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis Clin Pharmacol Ther 68 2000 238 249
52. G. Guarnieri, R. Situlin, G. Biolo Carnitine metabolism in uremia Am J Kidney Dis 38 suppl 1 2001 S63 S67
53. J.M. Hurot Carnitine et insufficiance renale. Revue systematique et meta-analyses Thesis 1988 University Claude Bernard Lyon Ufr Lyon Nord, France